GB1561247A - Polypeptides their preparation and use - Google Patents

Polypeptides their preparation and use Download PDF

Info

Publication number
GB1561247A
GB1561247A GB12086/77A GB1208677A GB1561247A GB 1561247 A GB1561247 A GB 1561247A GB 12086/77 A GB12086/77 A GB 12086/77A GB 1208677 A GB1208677 A GB 1208677A GB 1561247 A GB1561247 A GB 1561247A
Authority
GB
United Kingdom
Prior art keywords
compound
threonyl
pharmaceutically acceptable
acceptable salt
valyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB12086/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
State of Michigan
Original Assignee
State of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/772,851 external-priority patent/US4146614A/en
Application filed by State of Michigan filed Critical State of Michigan
Publication of GB1561247A publication Critical patent/GB1561247A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB12086/77A 1976-03-23 1977-03-22 Polypeptides their preparation and use Expired GB1561247A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66952676A 1976-03-23 1976-03-23
US05/772,851 US4146614A (en) 1976-03-23 1977-02-28 Threonyl-valyline leucine containing peptides and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1561247A true GB1561247A (en) 1980-02-13

Family

ID=27100128

Family Applications (1)

Application Number Title Priority Date Filing Date
GB12086/77A Expired GB1561247A (en) 1976-03-23 1977-03-22 Polypeptides their preparation and use

Country Status (13)

Country Link
JP (1) JPS52142015A (da)
AU (1) AU510679B2 (da)
CA (1) CA1103239A (da)
DE (1) DE2712781A1 (da)
DK (1) DK125177A (da)
FR (1) FR2351954A1 (da)
GB (1) GB1561247A (da)
GR (1) GR63642B (da)
LU (1) LU76998A1 (da)
NL (1) NL7703124A (da)
NO (1) NO771031L (da)
NZ (1) NZ183627A (da)
SE (1) SE7702925L (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62501147A (ja) * 1984-12-14 1987-05-07 オーストラリアン　コマーシャル　リサーチ　アンド　ディベロップメント　リミティド ヒト白血球エラスタ−ゼのアミノ酸阻害剤及びペプチド阻害剤
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬

Also Published As

Publication number Publication date
NZ183627A (en) 1980-02-21
FR2351954B1 (da) 1980-03-28
JPS52142015A (en) 1977-11-26
SE7702925L (sv) 1977-09-24
GR63642B (en) 1979-11-27
NL7703124A (nl) 1977-09-27
NO771031L (no) 1977-09-26
LU76998A1 (da) 1977-10-03
CA1103239A (en) 1981-06-16
DE2712781A1 (de) 1977-10-06
FR2351954A1 (fr) 1977-12-16
AU510679B2 (en) 1980-07-10
DK125177A (da) 1977-09-24
AU2317477A (en) 1978-09-14

Similar Documents

Publication Publication Date Title
US4229438A (en) Nonapeptides
US4261886A (en) Peptides having thymopoietin-like activity
EP0355572B1 (de) Peptidderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US4337247A (en) Tetrapeptidesemicarbazide derivatives and their production and use
CA1282550C (en) Methods and compositions for preparation of h-arg-x-z-y-tyr-r
US5100874A (en) Hydroxamic acid tetrapeptide derivatives
US4223016A (en) Peptides
US3472832A (en) Peptides related to caerulein
US3912705A (en) Thyrotropin releasing hormone analogs
EP0037516A1 (en) N-omega substituted derivatives of 1-Desamino-vasopressin analogs
Sakakibara et al. A synthesis of oxytocin
US4412988A (en) Hexapeptides
GB1582420A (en) Phenylamino phenylacetic acid amide compounds and processes for their preparation
US4748154A (en) Peptide derivatives, their production and use
GB1561247A (en) Polypeptides their preparation and use
US4146614A (en) Threonyl-valyline leucine containing peptides and pharmaceutical compositions
WO1993000359A1 (en) Modified peptides transportable into the central nervous system
US4369137A (en) N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide
EP0080283B1 (en) N-carboxyalkylproline-containing tripeptides
WO1981003329A1 (en) Oligopeptides with specific inhibiting properties of collagen induced aggregation,process for preparing the same and pharmaceutical compositions containing them
US3272790A (en) Polypeptides
US4784988A (en) Peptides correlated to lysozyme
Diaz et al. A large-scale synthesis of somatostatin for clinical use by a novel alternating solution/solid-phase procedure
US3790555A (en) Octapeptide derivative of gonadotropinreleasing hormone
RU2144038C1 (ru) Пептиды для ингибирования высвобождения пепсина, фармацевтическая композиция

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee